Novel therapeutic agents for MND with optimal pharmokinetic properties
Year Of Grant:
Motor Neuron Disease,
To modify the chemical structure of a new drug, BMC, to make it more fat soluble so that it can pass through the blood brain barrier. Once it is altered and able to enter the brain, this drug has the potential to treat MND.
<< Back To Grants And Publications List
by Melbourne ITC
© Bethlehem Griffiths Research